Business Snapshot and What’s Driving the Momentum
Rigetti has spent the past few years positioning itself as a full-stack quantum-classical computing firm, developing superconducting quantum processors and offering quantum-cloud access. It recently announced that its modular 36-qubit multi-chip system achieved a median two-qubit gate fidelity of 99.5%, halving its previous error rate.
In September 2025, Rigetti landed a three-year, US$5.8 million contract from the Air Force Research Laboratory (AFRL) that pairs it with Dutch startup QphoX to develop superconducting-to-optical quantum networking.
On the financial side, however, the picture remains mixed. For Q2 2025 the company reported revenue of just US$1.8 million and widening operating losses, revenue fell 42% year-over-year, while losses climbed 24 % to US$19.9 million.
The stock’s price has reflected that high-risk, high-reward narrative. Media reports show the market cap swelled to roughly US$17 billion amid rallies of several thousand percent for quantum peers. These milestones and contracts definitely lend legitimacy to the story.
But they also highlight that Rigetti’s commercial scaling remains nascent, and that much of the value today rests on future promise rather than current revenue. For any investor considering an entry now, the key is understanding how much of the future is already reflected in the price, and what must go right for the story to pay off.
Valuation, Risk and the Timing Question (Approx. 250 words)
With the stock’s recent leap, questions about valuation have moved front-and-centre. One analysis flagged that Rigetti is “massively overvalued”, noting that despite the nearly US$17.8 billion market cap the company lacks a clear path to profitability. Meanwhile, momentum plays have pressured the stock’s technicals, it surged sharply, then pulled back as some traders started reassessing timing.
In sectors such as quantum computing, timing matters. Much of the market is betting on a transformational shift, yet some commentators emphasise that widespread commercial usefulness remains years away. For an investor thinking about jumping in at this stage, the key questions become: has the compelling part of the story, awareness, excitement, major partner announcements, already been baked into the stock?
How much margin for error remains if technical or commercial milestones get delayed? In short, valuation suggests a high bar for further upside, and a significant risk if the narrative slips or execution slows. That doesn’t mean the company has no upside, but it does heighten the need for scrutiny and patience.
What Could Make or Break the Next Chapter
If Rigetti can convert its technical proof-points into scalable commercial systems, that transition would move the story from promise to revenue. Secure contracts like the AFRL deal give credibility but are small in absolute size today.
Increased government and institutional partnerships could broaden the addressable market beyond R&D labs. The recent deal with AFRL is one such example.
If broader macro tails such as increased national quantum-strategy funding or favourable regulation come into play, they could accelerate adoption.
Despite the recent announcements, revenue remains very low and inconsistent. A company with Q2 revenues of US$1.8 million is still far from commercial scale.
Competition is fierce. Other quantum players and large tech firms may outpace or out-invest pure plays. In a hype-driven sector, raising expectations and missing them can be painful.
If the market begins to demand near-term commercial returns rather than long-term vision, valuations may correct. One article warned that quantum stocks could plunge up to 60% if expectations are not met.
Execution risk is real, technical milestones in the lab don’t always translate smoothly into scalable systems, and timing delays or cost overruns are common in deep-tech ventures.
Rigetti is at the inflection point where the “can they deliver?” The question is becoming just as important as the “could they deliver?” question. From here, investors need to believe not just that the story is compelling, but that the company will meet meaningful milestones on a timeline that justifies its valuation.
Is It Too Late?
For an investor asking if it’s too late to buy Rigetti, the answer is nuanced. If one is comfortable placing a bet on long-horizon, speculative technology and is prepared to hold through volatility, there may still be meaningful upside. But if the expectation is for more immediate growth or a lower-risk entry point, the window may be narrower than it was a year ago.
The investment case today rests more on “patience and execution” than on “early positioning”. The hype appears mature; the next phase demands follow-through.
In practical terms, for a speculative investor who views quantum as potentially transformative in the 5-10 year timeframe, Rigetti can still have merit. For a more traditional investor seeking near-term returns or lower risk, the better opportunity may have been earlier.
In either case, carefully consider portfolio exposure, diversified risk, and whether you believe the company can hit the milestones behind the story.
Rigetti’s ascent is a vivid reminder of how sector-defining technologies can drive investor enthusiasm. But enthusiasm alone isn’t enough to ensure success. The next leg of this journey hinges on scaling, commercialisation and timing and at this stage, much of the speculative premium may already be embedded in the stock.
Discover more from Being Shivam
Subscribe to get the latest posts sent to your email.